Antifolate antineoplastic tablets produced for low-dose oral use in oncology and rheumatology. Sourced by clinic pharmacies and distributed by generic suppliers to treat leukemias, lymphomas, and autoimmune disorders. Integrated into protocols by oncologists in community and tertiary care facilities.